Cite
Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization
MLA
Bréchot C, et al. Early Treatment with Nitazoxanide Prevents Worsening of Mild and Moderate COVID-19 and Subsequent Hospitalization. Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........be9b767bcccfa0be50dfe472f25ad4b0&authtype=sso&custid=ns315887.
APA
Bréchot C, Rossignol J, Mogelnicki D, Matthew Cb, Bostick Bg, Fulgencio J, Vora Kn, & Oaks Jb. (2021). Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization.
Chicago
Bréchot C, Rossignol J, Mogelnicki D, Matthew Cb, Bostick Bg, Fulgencio J, Vora Kn, and Oaks Jb. 2021. “Early Treatment with Nitazoxanide Prevents Worsening of Mild and Moderate COVID-19 and Subsequent Hospitalization,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........be9b767bcccfa0be50dfe472f25ad4b0&authtype=sso&custid=ns315887.